McKesson Corporation · MCK · Next earnings

McKesson Corporation reports Wednesday, Feb 3, 2027

MCK reports after market close with consensus EPS at $10.91 and revenue at $113.18B. Last quarter: McKesson raises FY27 outlook as specialty growth and AI investments advance

Reports After market close90 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $10.91 Calendar consensus
Consensus revenue $113.18B Calendar consensus
Report date Feb 3, 2027 Wednesday, date estimated
Session After market close 90 days away

Where MCK left off: FY2027 Q1

Full report

McKesson raises FY27 outlook as specialty growth and AI investments advance

EPS surprise +3.9% Reported $9.93 vs $9.56
Revenue surprise +1.4% Reported $105.38B vs $103.88B
Stock move -0.7% Event window
Subsequent drift +5.7% Up to 20 sessions

Management raised FY27 adjusted EPS guidance to $44.20-$45.00 from the prior $43.80-$44.60 range.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Lower branded pharmaceutical pricing and branded-to-generic conversions could pressure economics.
  • Regulatory uncertainty around 340B reform, IRA Part B, and CMS initiatives remains.
  • The Medical-Surgical separation, acquisition integration, and free-cash-flow trajectory require execution.

Questions analysts left open

  • Whether Q1 outperformance is sustainable and repeatable.
  • Margin expansion in North American Pharmaceuticals amid policy and pricing changes.
  • Free cash flow growth and execution risk around the Medical-Surgical separation.

Ask FN2 about MCK next report

Choose a question to continue your research
What should I watch for in MCK's next earnings report?How did MCK guide last quarter, and is consensus above or below that?Give me the bull and bear case going into MCK earnings.

Free to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.

Get the MCK recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent MCK quarters

All MCK earnings
-0.7%FY2027 Q1-2.5%FY2026 Q4+16.5%FY2026 Q3+1.7%FY2026 Q2

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2027 Q1

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.